MY128929A - Vaccine against hepatitis a and hepatitis b - Google Patents

Vaccine against hepatitis a and hepatitis b

Info

Publication number
MY128929A
MY128929A MYPI99001705A MYPI9901705A MY128929A MY 128929 A MY128929 A MY 128929A MY PI99001705 A MYPI99001705 A MY PI99001705A MY PI9901705 A MYPI9901705 A MY PI9901705A MY 128929 A MY128929 A MY 128929A
Authority
MY
Malaysia
Prior art keywords
hepatitis
vaccine
vaccine against
formulations
yhdroxide
Prior art date
Application number
MYPI99001705A
Other languages
English (en)
Inventor
Artois Claude
Dr Michael J Clark
Thiriart Clothilde
Thoelen Stefan Gabriel Jozef
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of MY128929A publication Critical patent/MY128929A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MYPI99001705A 1998-05-01 1999-04-29 Vaccine against hepatitis a and hepatitis b MY128929A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9809507.8A GB9809507D0 (en) 1998-05-01 1998-05-01 Novel composition

Publications (1)

Publication Number Publication Date
MY128929A true MY128929A (en) 2007-02-28

Family

ID=10831426

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI99001705A MY128929A (en) 1998-05-01 1999-04-29 Vaccine against hepatitis a and hepatitis b

Country Status (28)

Country Link
EP (1) EP1073462B1 (enExample)
JP (2) JP5138843B2 (enExample)
KR (1) KR100612547B1 (enExample)
CN (1) CN1263509C (enExample)
AR (1) AR016987A1 (enExample)
AT (1) ATE345815T1 (enExample)
AU (1) AU743759B2 (enExample)
BR (1) BR9910157A (enExample)
CA (1) CA2331086C (enExample)
CO (1) CO5050367A1 (enExample)
CY (1) CY1107322T1 (enExample)
CZ (1) CZ301232B6 (enExample)
DE (1) DE69934108T2 (enExample)
DK (1) DK1073462T3 (enExample)
ES (1) ES2277437T3 (enExample)
GB (1) GB9809507D0 (enExample)
GC (1) GC0000101A (enExample)
HU (1) HU228209B1 (enExample)
IL (1) IL139269A0 (enExample)
MY (1) MY128929A (enExample)
NO (1) NO20005483L (enExample)
NZ (1) NZ507902A (enExample)
PL (1) PL190729B1 (enExample)
PT (1) PT1073462E (enExample)
TR (1) TR200003235T2 (enExample)
TW (1) TW553744B (enExample)
WO (1) WO1999056772A2 (enExample)
ZA (1) ZA200006118B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1513555A (zh) * 2003-07-31 2004-07-21 长春生物制品研究所 甲-乙型肝炎联合疫苗及其冻干制剂
EP1862176A1 (de) * 2006-05-31 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) * 2006-06-01 2007-12-05 Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH Ein Verfahren zur Herstellung einer Impfzusammensetzung
CN102198270B (zh) * 2011-05-16 2012-06-27 大连汉信生物制药有限公司 一种含铝佐剂乙肝疫苗的制备方法
KR101281098B1 (ko) * 2011-06-30 2013-07-02 주식회사 녹십자 Ｂ형 간염 바이러스 표면 항원상의 에피토프 및 이의 용도
CN102988975A (zh) * 2012-11-30 2013-03-27 深圳康泰生物制品股份有限公司 甲型、乙型肝炎联合疫苗及其制备方法
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
IL283039B2 (en) * 2018-11-13 2025-01-01 Variation Biotechnologies Inc Immunological preparations for the treatment of hepatitis B

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0349686A (ja) * 1989-07-11 1991-03-04 Smithkline Biologicals Sa レトロウイルスｇａｇ蛋白の真核生物細胞における発現
DE122010000016I1 (de) * 1992-05-23 2010-07-08 Glaxosmithkline Biolog Sa Kombinierte Impfstoffe, die Hepatitis-B-Oberflächen antigen und andere Antigene enthalten
GB9503863D0 (en) * 1995-02-25 1995-04-19 Smithkline Beecham Biolog Vaccine compositions
DE69731357T2 (de) * 1996-03-23 2006-02-02 The Research Foundation For Microbial Diseases Of Osaka University, Suita Funktionelles antigenfragment von tetanustoxin und tetanusvakzine

Also Published As

Publication number Publication date
AR016987A1 (es) 2001-08-01
CN1308547A (zh) 2001-08-15
HUP0101652A3 (en) 2004-10-28
KR20010043224A (ko) 2001-05-25
CZ20004061A3 (cs) 2001-04-11
PL190729B1 (pl) 2005-12-30
CO5050367A1 (es) 2001-06-27
DE69934108T2 (de) 2007-04-19
AU4137999A (en) 1999-11-23
CZ301232B6 (cs) 2009-12-16
JP5138843B2 (ja) 2013-02-06
NZ507902A (en) 2002-03-28
ZA200006118B (en) 2002-01-30
HU228209B1 (en) 2013-01-28
IL139269A0 (en) 2001-11-25
TR200003235T2 (tr) 2001-03-21
KR100612547B1 (ko) 2006-08-11
WO1999056772A2 (en) 1999-11-11
BR9910157A (pt) 2001-01-09
ES2277437T3 (es) 2007-07-01
ATE345815T1 (de) 2006-12-15
CN1263509C (zh) 2006-07-12
GB9809507D0 (en) 1998-07-01
NO20005483D0 (no) 2000-10-31
EP1073462A2 (en) 2001-02-07
NO20005483L (no) 2000-12-08
DK1073462T3 (da) 2007-02-26
CY1107322T1 (el) 2012-11-21
CA2331086A1 (en) 1999-11-11
PL344137A1 (en) 2001-10-08
GC0000101A (en) 2005-06-29
WO1999056772A3 (en) 2000-02-03
TW553744B (en) 2003-09-21
AU743759B2 (en) 2002-02-07
DE69934108D1 (de) 2007-01-04
PT1073462E (pt) 2007-01-31
JP2002513771A (ja) 2002-05-14
HUP0101652A1 (hu) 2001-09-28
EP1073462B1 (en) 2006-11-22
HK1034202A1 (en) 2001-10-19
JP2010209118A (ja) 2010-09-24
CA2331086C (en) 2010-06-22

Similar Documents

Publication Publication Date Title
MY113428A (en) Hepatitis b vaccine
NZ323973A (en) Vaccine compositions for intranasal administration comprising chitosan and use thereof
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
IL145982A0 (en) Vaccines
CA2182303A1 (fr) Procede de preparation d'un vecteur viral par recombinaison homologue intermoleculaire
AU7980794A (en) Methods and compositions for microencapsulation of antigens for use as vaccines
NZ506603A (en) Adjuvant compositions comprising polyoxyethylene ether or polyoxyethylene ester
IL154913A0 (en) Composition comprising immunogenic microparticles
CA2076744A1 (en) Viral Agent Associated with Mystery Swine Disease
MX9304089A (es) Uso de gm-csf como una vacuna adyuvante.
IL106968A0 (en) Potentiation of immunogenic response
DZ1706A1 (fr) Vaccin contre le virus de l'hepatite a.
AU9635998A (en) Solid dispersing vaccine composition for oral delivery
FR2669346B1 (fr) Vaccin a poxvirus recombinant contre le virus de la rougeole.
MY128929A (en) Vaccine against hepatitis a and hepatitis b
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
EP0586065A3 (en) Antigenic peptides for grouping hepatitis c virus, kit comprising the same and methods for its grouping using the same
MY127452A (en) Vaccines.
IS1914B (is) Ný LH-RH mótlyf, framleiðsla þeirra og notkun, ásamt læknislyfjum sem innihalda samsetningarnar og framleiðsla þeirra
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
ITTO950545A0 (it) Vaccino/composizioni terapautica di helycobacter pylori, loro prepara-zione ed impiego.
IL111023A0 (en) Albumin-conjugated tumor cell-free extracts, antigenic compositions comprising them, related abtibodies, and uses thereof
MX9708226A (es) Vacunas que contienen una saponina y un esterol.
GC0000171A (en) Novel vaccine formulations, methods for preparing them and their use in therapy